¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Disorders of tympanic membrane, unspecified"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • pharyngeal membrane
    Àεθ·
  • quadrangular membrane
    ³×¸ð¸·, »ç°¢¸·
  • resting membrane potential
    ¾ÈÁ¤¸·ÀüÀ§
  • reticular membrane
    ±×¹°¸·, ¸Á»ó¸·
  • reticulofibrous membrane bone
    ¼¼¸Á¼¶À¯¸·»À, ÀÏÂ÷¸·»À
  • retrocorneal membrane
    °¢¸·µÚ¸·, °¢¸·Èĸ·
  • spiral membrane
    ³ª¼±¸·, °í½Ç°è´Üº®
  • stapedial membrane
    µîÀÚ¸·
  • statoconial membrane
    ÆòÇü¸ð·¡¸·, ÆòÇü»ç¸·
  • sternal membrane
    º¹À帷, Èä°ñ¸·
  • suprapleural membrane
    °¡½¿¸·À§¸·, È丷»ó¸·
  • synovial membrane
    À±È°¸·, Ȱ¸·
  • semipermeable membrane
    ¹ÝÅõ¸·
  • serous membrane
    À帷
  • slit membrane
    Æ´»õ¸·, ¼¼±Ø¸·
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • membrane stabilizer
    ¸·¾ÈÁ¤Á¦
  • membrane transport
    ¸·¿î¹Ý
  • membrane control protein
    ¸·Á¶Àý´Ü¹é
  • membrane-derived oligosaccharide
    ¼¼Æ÷¸·À¯·¡¼Ò´ç·ù
  • mucous membrane
    Á¡¸·, Á¡¸·Ãþ
  • neovascular membrane
    ½Å»ýÇ÷°ü¸·
  • nictitating membrane
    ±ô¹Ú´«²¨Ç®
  • nuclear membrane
    ÇÙ¸·
  • obturator membrane
    Æó¼â¸·
  • olfactory membrane
    Èİ¢Á¡¸·
  • oncospheral membrane
    ¿©¼¸°¥°í¸®À¯Ã渷, À°±¸À¯Ã渷
  • oronasal membrane
    ÀÔÄÚ»çÀ̸·
  • oropharyngeal membrane
    ÀÔÀεθ·
  • otolithic membrane
    ÆòÇü¸ð·¡¸·
  • ovular membrane
    (¢¡vitelline membrane) ³­È²¸·
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • premature membrane rupture
    Á¶±â¸·ÆÄ¿­
  • preretinal membrane
    ¸Á¸·¾Õ¸·
  • presynaptic membrane
    ½Ã³³½ºÀü(ºÎ)¸· (¡­Ø¯).
  • presynaptic membrane
    ¿¬Á¢ÀÌÀü¸·
  • presynaptic membrane
    ½Ã³³½ºÀü(ºÎ)¸· (¡­Ø¯).
  • principal outer membrane protein (POMP)
    ÁÖ¿ä¿Ü¸·´Ü¹éÁú
  • proper membrane of semicircular duct
    ¹Ý°í¸®°ü°íÀ¯¸·, ¹Ý±Ô°ü°íÀ¯¸·(ÚâЮηͳ ?ÇØºÎ,À̺ñ
  • proper membrane of semicircular duct
    ¹Ý°í¸®°ü°íÀ¯¸·
  • protoplasmic membrane
    ¿øÇüÁú¸·(ê«û¡ òõد).
  • protoplasmic membrane
    ¿øÇüÁú¸·
  • pupillary membrane
    µ¿°ø¸·(ÔÚÍîØ¯).
  • pupillary membrane
    (µ¿°ø¸·)
  • pupillary membrane
    µ¿°ø¸·
  • pupillary membrane
    µ¿°ø¸·(ÔÚÍîØ¯).
  • quadrangular membrane
    »ç°¢¸·(ÞÌÊÇØ¯).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • posterior tympanic artery ³ª arteria tympanica p.
    µÚ°í½Çµ¿¸Æ, Èİí½Ç µ¿¸Æ(ý­ÍÕãøÔÑØæ).
  • recess of tympanic cavity
    °í½ÇÇÔ¿ä
  • recess of tympanic cavity
    °í½ÇÇÔ¿ä(ÍÕãøùèèê)
  • reflex, tympanic
    °í½Ç¹Ý»ç
  • sinus, tympanic
    °í½Çµ¿
  • small tympanic cavity
    ÀÛÀº°í½Ç, ¼Ò°í½Ç.
  • sulcus, tympanic
    °í½Ç±¸
  • sulcus, tympanic annular
    °í¸··û±¸
  • superior tympanic arteries
    »ó°í½Çµ¿¸Æ(ß¾ÍÕãøÔÑØæ).
  • superior tympanic artery
    À§°í½Çµ¿¸Æ
  • tube, tympanic ostium of auditory
    À̰ü°í½Ç±¸
  • tympanic
    °í½ÇÀÇ, °í¸·ÀÇ, °íâÀÇ
  • tympanic
    °í½Ç(ÍÕãø)ÀÇ, °í¸·ÀÇ, °íâ(ÍÕíó)ÀÇ.
  • tympanic air cells
    °í½Ç¹úÁý
  • tympanic angle
    °í½Ç°¢
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • Internal nuclear membrane
    ¼ÓÇÙ¸·
    [¿¾ ¿ë¾î] ³»ÇÙ¸·
  • Fertilization membrane
    ¼öÁ¤¸·
    [¿¾ ¿ë¾î] ¼öÁ¤¸·
  • Inferior synovial membrane
    ¾Æ·¡À±È°¸·
    [¿¾ ¿ë¾î] ÇÏȰ¾×¸·
  • Antebrachial interosseous membrane
    ¾Æ·¡ÆÈ»À»çÀ̸·
    [¿¾ ¿ë¾î] Àü¿Ï°ñ°£¸·
  • Interosseous membrane
    ¾Æ·¡ÆÈ»À»çÀ̸·
    [¿¾ ¿ë¾î] Àü¿Ï°ñ°£¸·
  • Vestibular wall of cochlear duct [Vestibular membrane]
    ¾È¶ã°è´Üº® [¾È¶ã¸·]
    [¿¾ ¿ë¾î] ÀüÁ¤°èº®
  • Anterior limiting membrane
    ¾Õ°æ°èÆÇ
    [¿¾ ¿ë¾î] Àü°æ°èÆÇ
  • Bowman`s membrane
    ¾Õ°æ°èÆÇ
    [¿¾ ¿ë¾î] Àü°æ°èÆÇ(Bowman¸·)
  • Anterior atlanto-occipital membrane
    ¾Õ°í¸®µÚÅë¼ö¸·
    [¿¾ ¿ë¾î] ÀüȯÃßÈĵθ·
  • Continuous basement membrane
    ¿¬¼Ó¹Ù´Ú¸·
    [¿¾ ¿ë¾î] ¿¬¼Ó¼º±âÀú¸·
  • Presynaptic membrane
    ¿¬Á¢ÀÌÀü¸·
    [¿¾ ¿ë¾î] ¿¬Á¢Àü¸·
  • Postsynaptic membrane
    ¿¬Á¢ÀÌÈĸ·
    [¿¾ ¿ë¾î] ¿¬Á¢Èĸ·
  • Fold of postsynaptic membrane
    ¿¬Á¢ÀÌÈĸ·ÁÖ¸§
    [¿¾ ¿ë¾î] ÈÄ¿¬Á¢ÁÖ¸§
  • Superior synovial membrane
    À§À±È°¸·
    [¿¾ ¿ë¾î] »óȰ¾×¸·
  • Vitreous membrane
    À¯¸®Ã¼¸·
    [¿¾ ¿ë¾î] ÃÊÀÚü¸·
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
CELDIC Commission on Emotional and Learning Disorders in Children
DDRT diseases, disorders and related topics
DIMS disorders of initiating and maintaining sleep
DOC date of conception; deoxycholate; deoxycorticosterone; died of other causes; disorders of cornificat...
DOES disorders of excessive sleepiness
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
AMT Amniotic membrane transplantation
GBM Anti-glomerular basement membrane
anti-GBM Anti-glomerular basement membrane
TBM Anti-tubular basement membrane
BMZ Antibasement membrane zone
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
child reactive disorders Reactions to an event or set of events which are considered to be of pathological degree, that have not developed into a neurosis, psychosis, or personality disorder with fixed patterns.
(12 Dec 1998)
peroxisomal disorders A heterogeneous group of inherited metabolic disorders in which peroxisomes are either defective or totally lacking and/or there is a dysfunction of single or multiple peroxisomal enzymes. Patients show metabolic defects in all the major biosynthetic peroxisomal pathways, especially failure to synthesise ether lipids, or to oxidise long-chain fatty acids, and accumulate bile acid precursors. The disorders include zellweger syndrome, infantile refsum disease, rhizomelic chondrodysplasia (chondrodysplasia punctata, rhizomelic), and hyperpipecolic acidemia.
(12 Dec 1998)
personality disorders A major deviation from normal patterns of behaviour.
(12 Dec 1998)
growth disorders Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. The concept includes both acceleration and retardation of growth.
(12 Dec 1998)
phagocytic dysfunction disorders immunodeficiency Suppression in number or function of phagocytic cells such as in chronic granulomatous disease.
Synonym: phagocytic dysfunction disorders immunodeficiency.
Origin: L. Phagedaena, Gr Phago, To eat.
(05 Mar 2000)
ciliary motility disorders Disorders characterised by abnormal ciliary movement in the nose, paranasal sinuses, respiratory tract, and spermatozoa. Electron microscopy of the cilia shows that dynein arms are missing. The disorders manifest as kartagener triad (kartagener's syndrome), chronic respiratory disorders, chronic sinusitis, and/or chronic otitis.
(12 Dec 1998)
phobic disorders Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognises the fear as excessive or unreasonable.
(12 Dec 1998)
civil disorders Deliberate and planned acts of unlawful behaviour engaged in by aggrieved segments of the population in seeking social change.
(12 Dec 1998)
phosphorus metabolism disorders Disorders in the processing of phosphorus in the body: its absorption, transport, storage, and utilization.
(12 Dec 1998)
photosensitivity disorders Abnormal responses to sunlight or artificial light due to extreme reactivity of light-absorbing molecules in tissues. It refers almost exclusively to skin photosensitivity, including sunburn, reactions due to repeated prolonged exposure in the absence of photosensitizing factors, and reactions requiring photosensitizing factors such as photosensitizing agents and certain diseases. With restricted reference to skin tissue, it does not include photosensitivity of the eye to light, as in photophobia or photosensitive epilepsy.
(12 Dec 1998)
mood disorders Those disorders that have a disturbance in mood as their predominant feature.
(12 Dec 1998)
combat disorders Neurotic reactions to unusual, severe, or overwhelming military stress.
(12 Dec 1998)
communication disorders Disorders characterised by the individual's inability to comprehend or share ideas or feelings because of impairment of language, speech, or hearing.
(12 Dec 1998)
motor skills disorders Marked impairments in the development of motor coordination such that the impairment interferes with activities of daily living.
(12 Dec 1998)
platelet function disorders <haematology> Platelet function can be affected by a number of different disease processes including polycythaemia vera, leukaemia, myelofibrosis, renal failure, multiple myeloma and some medications (for example penicillins, salicylates, phenothiazines).
Disturbed blood clotting can be manifested by: easy bruising, bleeding gums, nosebleeds, abnormal vaginal bleeding, rectal bleeding, skin rash, vomiting blood, coughing up blood or blood in the urine. A measure of bleeding time and coagulation profile will be part of the evaluation.
(31 Dec 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
ÅëÇÕ°Ë»ö ¿Ï·á